Carl Zeiss Meditec Unveils New Ophthalmic Solutions at the European
Society of Cataract and Refracti
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Three New Combined Product Offerings Designed to Support the EntireTreatment SpectrumJENA - September 11, 2009. Carl Zeiss Meditec will showcase threenew ophthalmic treatment solutions at the European Society ofCataract and Refractive Surgery (ESCRS) meeting in Barcelona, Spain. These new diagnostic and surgical offerings are designed to worktogether to improve productivity, workflow and clinical outcomes thatare critical in today's healthcare environment.Carl Zeiss Solutions include:ZEISS Toric Solution - a combination of tools that allow physiciansto implant and align toric lenses faster and easierZEISS Ophthalmic Data Management Solutions - a completely integratedplatform that stores all diagnostic patient data, thus providing apaperless diagnostic and surgical workflowZEISS Refractive Laser Solution - the most comprehensive range ofapplications as well as fully integrated flow of data and patienthandling."In the face of growing patient demands and practice managementchallenges, the need for the eyecare industry to provide dedicatedsolutions that improve efficiency processes while supporting clinicaloutcomes is more critical than ever before," said Dr. MichaelKaschke, President and CEO of Carl Zeiss Meditec. "In addition toour long tradition of spearheading technological developments inophthalmology, we are working to provide answers to the newchallenges that our customers face. Our 'Solutions' offering atESCRS utilizes trusted tools and applications to deliver provenresults."ZEISS Toric SolutionThis combined solution is designed to provide a fast and reliabletoric lens surgery to astigmatic patients with increased safetythrough an integrated workflow. Starting with the pre-operativebiometry, the gold-standard IOL Master ensures highly accurate,precise outcomes through a totally non-contact measurement. Following biometry measurements, the calculation of ZEISS toric IOLscan be easily done with the new Z CALC: an online calculatorproviding customized results with modifiable sphere and cylinderpowers, for excellent refractive outcomes. In the OR, surgicalmicroscopes (like the OPMI Lumera family) ensure excellent clarityand an outstanding red reflex to support the implementation of toricIOLs like the AT LISA toric, the one and only MICS IOL that cansimultaneously correct sphere, cylinder and associated presbyopia.Finally, the innovative new video supported tool Z ALIGN, a functionof CALLISTO eye, enables surgeons to accurately position the toricIOL using an integrated eye tracking system.ZEISS Ophthalmic Data Management SolutionCarl Zeiss presents the first fully integrated platform whichconnects all ophthalmic systems and links the diagnostic and surgeryprocedures: Diagnostic reports and images are stored centrally andcan be viewed from any location in or outside the ophthalmic practice- even in the operating room. The modular architecture of thisscalable solution guarantees maximum flexibility and meets thedifferent needs of ophthalmic practices and surgery centers of anysize. The immediate benefit of an integrated workflow even on a verysmall scale can be experienced e.g. at the new Retina workstation,which allows a complete retinal exam at once. The integratingcomponents of the ZEISS Ophthalmic Data Management Solution are theFORUM image and report management system and the CALLISTO eye ORmanagement system.ZEISS Refractive Laser SolutionThe combination of MEL 80 excimer laser, CRS-Master custom treatmentplatform and VisuMax femtosecond laser offers the most extensiverange of applications for today and tomorrow. Carl Zeiss Meditec ison track to commercializing the FLEx all-in-one procedure as of ASCRS2010. Recent clinical outcomes are very positive - FLEx has reachedand partially exceeds LASIK clinical outcomes and represents thefirst step towards minimally invasive laser vision correction. Thescope of therapy offered by the MEL 80 excimer platform will besignificantly expanded by the newly introduced, retrofittable LaserBlended Vision module that alleviates presbyopia. Due the designphilosophy of the Carl Zeiss Meditec technology platform, all systemsin the field are upgradeable to the most recent applications.Complementing the wide ophthalmic portfolio, the company isshowcasing additional products, including:Visante omni - shown for the first time at a European congress as acomplete system - is the first system to combine OCT and Placido disktechnologies, providing comprehensive anterior and posteriortopography for improved patient selection and care. It allows therefractive surgeon to identify pre-existing corneal abnormalities,such as keratoconus, in their earliest stages.Visalis 100 - Launched in February 2009, Visalis 100 is a reliable,safe phaco machine with affordable accessories costs per surgery.Cirrus HD-OCT, the modern OCT standard, is now available in twomodels: Cirrus HD-OCT 400 and Cirrus HD-OCT 4000. The new model400's Live OCT Fundus(TM) technology streamlines the instrument'sscan targeting optics to deliver proven Cirrus performance and corediagnostic applications at an affordable price. The new model willjoin the current Cirrus HD-OCT 4000, today's first choice OCT for thefull spectrum of patient care. Both systems are quick and easy tooperate, providing unique views of the retina due to precisionsegmentation algorithms and superb quality images, and provide thebest possible basis for reliable diagnosis and treatment decisionsfor pre and post cataract surgical assessment, management of retinaldisorders and glaucoma progression analysis.ESCRS visitors will have the opportunity to attend Carl Zeisslectures and symposia, as well as live presentations anddemonstrations at booth G1. In addition, physicians can gainhands-on experience with many of the company's future surgical anddiagnostic technologies.Press contacts:Eva Sesselmann Patrick KoflerCorporate Communications Investor RelationsCarl Zeiss Meditec AG Carl Zeiss Meditec AGGöschwitzer Straÿe 51-52 Göschwitzer Straÿe 51-5207745 Jena, Germany 07745 Jena, GermanyPhone: +49 3641 220-331 Phone: +49 3641 220-106Fax: +49 3641 220-112 Fax: +49 3641 220-117E-mail: press(at)meditec.zeiss.com E-mail: investors(at)meditec.zeiss.comBrief profileCarl Zeiss Meditec AG (ISIN: DE0005313704) is one of the world'sleading medical technology companies.The Company supplies innovative technologies and application-orientedsolutions which enable doctors to improve the quality of life oftheir patients. The Company offers complete solutions, includingimplants and consumables, to diagnose and treat ophthalmic diseases.In the fields of microsurgery the Company provides innovativevisualization solutions. The medical technology portfolio of CarlZeiss Meditec is rounded off by promising future-orientedtechnologies such as intraoperative radiotherapy.The Company's around 2,100 employees generated revenues of about EUR600 million in fiscal year 2007/08 (ended Sept. 30). Theheadquarters of Carl Zeiss Meditec are located in Jena, Germany. Inaddition to other subsidiaries in Germany, the Company is representedby over 50 percent of its employees at sites in the USA, Japan, Spainand France.35 percent of Carl Zeiss Meditec shares are in free float. Theremaining 65 percent are held by Carl Zeiss AG, one of the world'sleading groups in the optical and opto-electronic industry. The fiveindependently run business segments of Carl Zeiss AG operate in thefuture-oriented markets "Medical and Research Solutions", "IndustrialSolutions" and "Lifestyle Products". Carl Zeiss AG is headquarteredin Oberkochen, Germany. During fiscal year 2007/08 (ended Sept. 30)the company generated revenues of about EUR 2.7 billion. Carl Zeisshas around 13,000 employees in more than 30 countries, including over8,000 in Germany.For further information, please visit our website at:http://www.meditec.zeiss.com --- End of Message ---Carl Zeiss Meditec AGGoeschwitzer Strasse 51-52 Jena GermanyWKN: 531370; ISIN: DE0005313704; Index: Prime All Share, TECH All Share, TecDAX;Listed: Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Prime Standard in Frankfurter Wertpapierbörse, Regulierter Markt in Frankfurter Wertpapierbörse;
Datum: 11.09.2009 - 11:36 Uhr
Sprache: Deutsch
News-ID 5714
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 555 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Carl Zeiss Meditec Unveils New Ophthalmic Solutions at the European
Society of Cataract and Refracti"
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
